Categories AlphaGraphs, Earnings, Health Care
Key highlights from AbbVie’s (ABBV) Q2 2025 earnings results
AbbVie (NYSE: ABBV) reported its second quarter 2025 earnings results today.
Worldwide net revenues were $15.4 billion, up 6.6% on a reported basis, or 6.5% on an operational basis compared to the same period a year ago.
Net earnings attributable to AbbVie Inc. were $938 million, or $0.52 per share, compared to $1.37 billion, or $0.77 per share, last year. Adjusted EPS of $2.97 was up 12.1% year-over-year.
AbbVie expects adjusted EPS for the full year of 2025 to be $11.88-12.08.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Target (TGT) expected to report lower Q3 2025 sales and profit
Target Corporation (NYSE: TGT) is navigating a challenging retail landscape ahead of next week's earnings, as sales and margins face pressure from economic uncertainty and restrained consumer demand. With a
Home Depot (HD) expected to report higher revenue and earnings in Q3 2025
Shares of The Home Depot (NYSE: HD) dipped over 1% on Monday. The stock has dropped 5% in the past three months. The home improvement retailer is scheduled to report
Tyson Foods (TSN) Q4 2025 adj. earnings beat unexpectedly; sales up 2%
Tyson Foods, Inc. (NYSE: TSN), a leading processor and marketer of chicken, beef, and pork, reported stronger-than-expected earnings for the fourth quarter of fiscal 2025 when the company's sales rose
